Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Douglas W. Arthur, MD
Virginia Commonwealth University
Study Chair - Frank A. Vicini, MD, FACR
St. Joseph Mercy Oakland
Principal Investigator - Gary M. Freedman, MD
University of Pennsylvania
Study Chair - Julia R. White, MD
Ohio State University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
415 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Bcca-Vancouver Cancer Centre
Vancouver, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Atlantic Health Sciences Corporation-Saint John Regional Hospital
Saint John, New Brunswick, Canada
- Grand River Regional Cancer Centre at Grand River Hospital
Kitchener, Ontario, Canada
- London Regional Cancer Program
London, Ontario, Canada
- Stronach Regional Health Centre at Southlake
Newmarket, Ontario, Canada
- Irving Greenberg Family Cancer Centre
Ottawa, Ontario, Canada
- Ottawa Hospital and Cancer Center-General Campus
Ottawa, Ontario, Canada
- Ottawa Hospital-Civic Campus
Ottawa, Ontario, Canada
- Windsor Regional Cancer Centre
Windsor, Ontario, Canada
- Hopital de la Cite-de-la-Sante
Laval, Quebec, Canada
- Chum - Centre Hospitalier de L'Universite de Montreal
Montreal, Quebec, Canada
- Chum - Hopital Notre-Dame
Montreal, Quebec, Canada
- Ciusssemtl-Hopital Maisonneuve-Rosemont
Montreal, Quebec, Canada
- Mcgill University Department of Oncology
Montreal, Quebec, Canada
- the Research Institute of the Mcgill University Health Centre (muhc)
Montreal, Quebec, Canada
- Chu de Quebec-L'Hotel-Dieu de Quebec (hdq)
Québec, Quebec, Canada
- Centre Hospitalier Universitaire de Sherbrooke-Fleurimont
Sherbrooke, Quebec, Canada
- Allan Blair Cancer Centre
Regina, Saskatchewan, Canada
- Pamela Youde Nethersole Eastern Hospital
Chai Wan, Hong Kong
- Rabin Medical Center
Petah Tikva, Israel
- Chaim Sheba Medical Center
Tel Litwinsky, Israel
- Shizuoka Cancer Center
Shizuoka, Suntou, Japan
- National Cancer Centre Singapore
Singapore, Singapore
- National University Hospital Singapore
Singapore, Singapore
- National Cancer Center-Korea
Goyang-si, Gyeonggi-do, South Korea
- Yonsei University Health System-Severance Hospital
Seoul, South Korea
- Kantonsspital Aarau
Aarau, Switzerland
- the Kirklin Clinic at Acton Road
Birmingham, Alabama, United States
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- 21st Century Oncology-Scottsdale
Scottsdale, Arizona, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Arizona Oncology Associates-West Orange Grove
Tucson, Arizona, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- Chi Saint Vincent Cancer Center Hot Springs
Hot Springs, Arkansas, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Sutter Cancer Centers Radiation Oncology Services-Auburn
Auburn, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Cameron Park
Cameron Park, California, United States
- Mercy San Juan Medical Center
Carmichael, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 May 2011
- Primary completion
- 25 Jan 2022
- Completion
- —
- Last update posted
- 5 Mar 2026
- Registered enrollment
- 2,354
- Registry id
- NCT01349322
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.